Cytokinetics reported $-76086000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Amgen AMGN:US $ 1884M 1420M
Arca Biopharma ABIO:US $ -4.1M 2.11M
Bayer BAYN:GR € 85M 2420M
Biogen BIIB:US $ 329.2M 119.3M
Brainstorm Cell Therapeutics BCLI:US $ -5.34M 0.93M
Bristol Myers Squibb BMY:US $ 1546M 491M
Cytokinetics CYTK:US $ -76.09M 14.53M
Eisai 4523:JP Y 4024M 38138M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Exelixis EXEL:US $ 38.2M 57.89M
Genocea Biosciences GNCA:US $ -3.62M 0.69M
Geron GERN:US $ -26.7M 2.88M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Ligand Pharmaceuticals LGND:US $ 13.72M 17M
Merk MRK:US $ 4567M 3022M
Novartis NOVN:VX SF 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M